357例癌痛临床路径管理病例分析  

ANALYSIS OF 357 CASES IN CANCER PAIN CLINICAL PATHWAY

作　　者：刘姗[1] 杨敏[1] 王延风[1] 吴艳芳[1] 李建英[1] 吴熙[1] 徐海燕[1] 邓颖冰 宋晨鑫[1] 邹宝华[1] 丛明华[1] 边志民[1] 李宁 杨渤彦[1] 田乐[1] 朱继庆[1] 吴晓明[1] 于雷[1] 

机构地区：[1]国家癌症中心/中国医学科学院北京协和医学院肿瘤医院综合科,北京100021

出　　处：《中国疼痛医学杂志》2017年第6期443-446,共4页Chinese Journal of Pain Medicine

摘　　要：目的:总结并分析进入癌痛临床路径管理病人的临床资料及治疗过程。方法:对2013.3.22-2015.3.26进入癌痛临床路径的357例病人进行研究,总结并分析其疼痛数字评分(numerical rating scale,NRS)、爆发痛(breakthrough pain,BTP)及癌痛治疗过程等情况。结果:入院时根据其NRS评分,轻度疼痛病人135例(37.8%),中度疼痛155例(43.4%),重度疼痛67例(18.8%)。172例(48.2%)有爆发痛,其中21例(5.9%)爆发痛≥3次/日。死亡病人共68例(19.0%)。其余病人出院时轻度疼痛病人273例(76.5%),中度疼痛病人15例(4.2%),重度疼痛病人1例(0.3%)。39例(10.9%)病人有爆发痛,其中4例(1.1%)爆发痛≥3次/日。结论:进入癌痛临床路径管理的病人经治疗其癌痛程度及爆发痛都显著减轻。Objective： To summarize and analyze the clinical data and treatment of the cancer pain clinical pathway. Methods： There were 357 cases in cancer pain clinical pathway, from March 22, 2013 to March 26, 2015, were involved. Their cancer pain numerical rating scale（NRS）, breakthrough pain（BTP） and treatment are summarized and analyzed. Results： On admission there are 135 cases（37.8%） with mild pain, 155 cases（43.4%） with moderate pain, 67 cases（18.8%） with severe pain. 172 cases（48.2%） have BTP, of whom 21 have BTP 3 times/day or more. At discharge 68 patients are dead. In the other 289 patients there are 273 cases（76.5%） with mild pain, 15 cases（4.2%） with moderate pain, 1 case（0.3%） with severe pain. 39 cases（10.9%） have BTP, of whom 4 have BTP 3 times/day or more. Conclusions： The intensity and BTP of the patients’ cancer pain are significantly decreased under the management of cancer pain clinical pathway.

关 键 词：癌痛 临床路径 

分 类 号：R473.73[医药卫生—护理学]